Several hundred people received free blood pressure screenings at different locations throughout the Mount Sinai Health System in May, during National High Blood Pressure Education Month. Regular screenings are an important step in helping to control high blood pressure, which is a leading cause of cardiovascular disease and stroke, but often has no warning signs. Mount Sinai Heart hosted the screenings and distributed educational information at Mount Sinai St. Luke’s, Mount Sinai Beth Israel, The Mount Sinai Hospital, Mount Sinai Beth Israel Brooklyn, and Mount Sinai Queens.
The Mount Sinai Hospital and Jupiter Medical Center, in Jupiter, Florida, recently announced a new partnership that promises to enhance the quality of cardiovascular care in South Florida and throughout the state with the creation of Mount Sinai Heart New York at Jupiter Medical Center. The collaboration encompasses nearly all facets of cardiac care and calls for physicians at both hospitals to share knowledge, experience, best practices, evidence-based medicine, quality protocols, and clinical pathways for improved patient care. Read more
The New York State Department of Health recently awarded The Mount Sinai Hospital’s Cardiac Catheterization (Cath) Laboratory the highest “two-star” safety rating for percutaneous coronary interventions (PCI) in overall and nonemergency cases. This marks the 16th consecutive year that the Cath Lab, or one of its physicians, has received this prestigious two-star rating for safety when performing PCI. The minimally invasive procedure, also known as angioplasty, is used to diagnose and treat patients with heart disease or blocked arteries.
The Mount Sinai Hospital Cardiac Care Unit (CCU) was awarded a 2014 Beacon Award for Excellence from the American Association of Critical-Care Nurses (AACN), the leading society of acute- and critical-care nurses.
The Mount Sinai Hospital is one of three institutions in New York State, and one of one hundred in the nation, selected to study the safety and effectiveness of an implantable cranial nerve stimulation device for heart failure patients with debilitating fatigue, shortness of breath, and heart arrhythmias.